Type II variation for application NMPA-2021-0044. Type II variation: Labeling Change for Neprilozone — routine update

Variation Number
NMPA-2021-0044-V244
Type
Type II
Application
Status
Active
Fee
€9,675
Submitted
2024-02-05
Approved
—
Description

Type II variation: Labeling Change for Neprilozone — routine update